aTyr Pharma, Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2024 | — | $70.0M | $11.1M |
| FY2025 | — | $67.5M | $10.7M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2024 | — | $70.0M | $11.1M |
| FY2025 | — | $67.5M | $10.7M |